When was Cryoniss founded?

Cryoniss was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is Cryoniss located?

Cryoniss is headquartered in Macclesfield, United Kingdom.

Who is the current CEO of Cryoniss?

Sonia Houghton of Cryoniss. They have also founded 1 company.

Which legal entities is Cryoniss associated with?

Cryoniss is associated with CRYONISS LTD and 1 other.

How many employees does Cryoniss have?

As of Mar 31, 2022, the latest employee count at Cryoniss is 9.

Is Cryoniss a funded company?

Cryoniss is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 18, 2022.

When was the latest funding round of Cryoniss?

Cryoniss' latest funding was a $***** Seed round on Jan 18, 2022, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United Kingdom, the Life Sciences Platforms and Tools sector has seen $124M in funding in 2026 to date.

Where does Cryoniss rank among its competitors?

Cryoniss ranks 4th amongst 96 active competitors, of which 10 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was iSpecimen, which secured $2.5M in May, 2026.

Who are the top competitors of Cryoniss?

Cryoniss' top competitors include iSpecimen, Cryoport and GenVault Corporation. Among them, iSpecimen secured the most recent funding round in May, 2026.

Cryoniss - 2026 Company Profile, Team, Funding, Competitors & Financials

Cryoniss is an acquired company based in Macclesfield (United Kingdom), founded in 2018 by Sonia Houghton and Phil Hargreaves. It operates as a Provider of biobanking services for life sciences industries. Cryoniss has raised $683K in funding from Maven Capital Partners. The company has 96 active competitors, including 10 funded and 21 that have exited. Its top competitors include companies like iSpecimen, Cryoport and GenVault Corporation.

Company Details

Provider of biobanking services for life sciences industries. The portfolio of service includes the storage of human biological samples in vapor-phase liquid nitrogen and ambient temperature. The company also offers storage of clinical samples from phase and bioreagents such as glycerol stocks, DNA, frozen cultures antibodies at ambient temperature.

Website: www.cryoniss.com/
Social
Email ID: *****@cryoniss.com
Phone Number: +44 **********

Key Metrics

Founded Year

2018

Location

Macclesfield, United Kingdom

Stage

Acquired

Total Funding

$683K in 1 round

Latest Funding Round

Seed, Jan 18, 2022, $*****

Investors

Maven Capital Partners & 16 more

Ranked

4^th among 96 active competitors

Employee Count

9 as on Mar 31, 2022

Similar Companies

iSpecimen & 123 more

Exit Details

Acquired by Biofortuna (May 10, 2024)

View Cryoniss' full profile

Cryoniss is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CRYONIS LTD CIN: 15191102 , United Kingdom, Active	Oct 05, 2023	-	-
CRYONISS LTD CIN: 11235556 , United Kingdom, Active	Mar 05, 2018	-	3 (As on Mar 31, 2021)

Cryoniss got acquired by Biofortuna on May 10, 2024.

Click here to take a look at Cryoniss's acquisition in detail

Cryoniss has raised a total funding of $683K over 1 round. Its latest funding round was a Seed round on Jan 18, 2022 for $*****. 1 investor participated in its latest round. Cryoniss has 3 institutional investors and 14 angel investors.

Here is the list of recent funding rounds of Cryoniss:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 18, 2022	9339741	Seed	1021186	5904502	4390129	9210815

Access funding benchmarks and valuations. Sign up today!

View details of Cryoniss's funding rounds and investors

The founders of Cryoniss are Sonia Houghton and Phil Hargreaves. Sonia Houghton is the CEO of Cryoniss.

Here are the details of Cryoniss' key team members:

Sonia Houghton: Co-Founder & CEO of Cryoniss.
Contact Info: 1 email address
Phil Hargreaves: Co-Founder & COO of Cryoniss.

View details of Cryoniss's Founder profiles and Board Members

Cryoniss' employee count trend

Cryoniss has 9 employees as of Mar 22. The total employee count is 200.0% more than what it was in Mar 21. Here is Cryoniss's employee count trend over the years:

Uncover Cryoniss' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cryoniss include iSpecimen, Cryoport and GenVault Corporation. Here is the list of Top 10 competitors of Cryoniss, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	iSpecimen 2009, Lexington (United States), Public	Provider of a biorepository of human clinical specimens	$11.9M	MassChallenge	46/100
2nd	Cryoport 2019, Brentwood (United States), Public	Provider of supply chain solutions for cell and gene therapies	-	-	46/100
3rd	GenVault Corporation 2000, Carlsbad (United States), Acquired	Biorepository providing secure, compliant storage and transport for biological samples	$47.8M	Cross Creek, QuestMark Partners & 2 others	45/100
4th	Cryoniss 2018, Macclesfield (United Kingdom), Acquired	Provider of biobanking services for life sciences industries	$683K	Bamburgh Capital, Northern Powerhouse Investment Fund ... & 15 others	43/100
5th	AminoChain 2022, New York City (United States), Seed	A blockchain-based platform for tokenizing and incentivizing stem cell donations	$7.07M	Andreessen Horowitz, Plug and Play Tech Center ... & 1 others	42/100
6th	Indivumed 2002, Hamburg (Germany), Funding Raised	Specimen biobank, Drug and biomarker service provider	-	European Investment Bank, National Cancer Institute ... Read more	42/100
7th	CBR 1992, Los Angeles (United States), Acquired	Provides services for cord blood and cord tissue stem cells preservation	$18M	ABS Capital, HLM Venture Partners & 4 others	40/100
8th	Dadi 2019, Brooklyn (United States), Acquired	Provider of sperm storage and analysis services	$7M	Firstminute Capital, TCG & 5 others	40/100
9th	ImmunoTek 2012, Port Orange (United States), Acquired	Provider of collection and procurement of human blood plasma from public	-	-	40/100
10th	ViaCell 1994, Cambridge (United States), Acquired	Provider of services for collecting and preserving umbilical cord blood stem cells	$63M	EDBI, Nomura & 3 others	40/100